KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Gains from Investment Securities (2016 - 2025)

Arbutus Biopharma (ABUS) has disclosed Gains from Investment Securities for 16 consecutive years, with -$153000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 108.1% to -$153000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $674000.0 through Dec 2025, down 74.32% year-over-year, with the annual reading at $674000.0 for FY2025, 74.32% down from the prior year.
  • Gains from Investment Securities hit -$153000.0 in Q4 2025 for Arbutus Biopharma, down from $227000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.9 million in Q4 2024 to a low of -$636000.0 in Q2 2023.
  • Historically, Gains from Investment Securities has averaged $273210.5 across 5 years, with a median of $211000.0 in 2024.
  • Biggest five-year swings in Gains from Investment Securities: surged 160.57% in 2021 and later crashed 423.32% in 2022.
  • Year by year, Gains from Investment Securities stood at $193000.0 in 2021, then plummeted by 423.32% to -$624000.0 in 2022, then surged by 161.38% to $383000.0 in 2023, then surged by 393.47% to $1.9 million in 2024, then crashed by 108.1% to -$153000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for ABUS at -$153000.0 in Q4 2025, $227000.0 in Q3 2025, and $300000.0 in Q2 2025.